UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Global Blood Therapeutics is implementing good security practices.
GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its late-stage product candidate, voxelotor (previously called GBT440), for the treatment of sickle cell disease.
This report shows a preliminary security rating for Global Blood Therapeutics. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Data classification is the process of organizing structured and unstructured data into categories, ...
Social engineering is an attack vector that exploits human psychology and susceptibility to ...
Compare Global Blood Therapeutics's security performance with other companies